Hospital Ramón y Cajal -ko ikertzaileekin lankidetzan egindako argitalpenak (18)

2022

  1. Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity

    Biomedicines, Vol. 10, Núm. 3

  2. Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies

    Current Oncology, Vol. 29, Núm. 4, pp. 2442-2453

  3. Prognostic role of IRS-4 in the survival of patients with pancreatic cancer

    Histology and histopathology, Vol. 37, Núm. 5, pp. 449-459

2021

  1. Applications of polymeric composites in bone tissue engineering and jawbone regeneration

    Polymers, Vol. 13, Núm. 19

  2. Expansion of CD4 T lymphocytes expressing interleukin 17 and tumor necrosis factor in patients with major depressive disorder

    Journal of Personalized Medicine, Vol. 11, Núm. 3

  3. Systemic inflammation and the breakdown of intestinal homeostasis are key events in chronic spinal cord injury patients

    International Journal of Molecular Sciences, Vol. 22, Núm. 2, pp. 1-22

2020

  1. Blunted Expansion of Regulatory T Lymphocytes Is Associated With Increased Bacterial Translocation in Patients With Major Depressive Disorder

    Frontiers in Psychiatry, Vol. 11

2019

  1. Intestinal Immune Dysregulation Driven by Dysbiosis Promotes Barrier Disruption and Bacterial Translocation in Rats With Cirrhosis

    Hepatology, Vol. 70, Núm. 3, pp. 925-938

2013

  1. Defective thymopoiesis and poor peripheral homeostatic replenishment of T-helper cells cause T-cell lymphopenia in cirrhosis

    Journal of Hepatology, Vol. 59, Núm. 4, pp. 723-730

2012

  1. Interaction between intestinal dendritic cells and bacteria translocated from the gut in rats with cirrhosis

    Hepatology, Vol. 56, Núm. 5, pp. 1861-1869

2011

  1. Loss of surface antigens is a conserved feature of apoptotic lymphocytes from several mammalian species

    Cellular Immunology, Vol. 271, Núm. 1, pp. 163-172

2010

  1. Critical role of the liver in the induction of systemic inflammation in rats with preascitic cirrhosis

    Hepatology, Vol. 52, Núm. 6, pp. 2086-2095

  2. The biological response modifier AM3 attenuates the inflammatory cell response and hepatic fibrosis in rats with biliary cirrhosis

    Gut, Vol. 59, Núm. 7, pp. 943-952

2009

  1. RNAi-mediated silencing of insulin receptor substrate-4 enhances actinomycin D- and tumor necrosis factor-α-induced cell death in hepatocarcinoma cancer cell lines

    Journal of Cellular Biochemistry, Vol. 108, Núm. 6, pp. 1292-1301

2008

  1. Origen hepático de la activación temprana del sistema inmune en ratas cirróticas compensadas

    XXXIII Congreso Anual de la Fundación y Asociación Española para el Estudio del Hígado

2005

  1. Mesenteric Th1 polarization and monocyte TNF-α production: First steps to systemic inflammation in rats with cirrhosis

    Hepatology, Vol. 42, Núm. 2, pp. 411-419

2004

  1. Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: Amelioration with norfloxacin

    Journal of Hepatology, Vol. 40, Núm. 4, pp. 624-631

2003

  1. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement

    Hepatology, Vol. 37, Núm. 1, pp. 208-217